Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation

NCT07297719 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2026-01-16

No results posted yet for this study

Summary

Main evaluation of glistening at least 24 Months post-IOL implantation

Conditions

  • Cataract Senile

Sponsors & Collaborators

  • Carl Zeiss Meditec AG

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-25
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07297719 on ClinicalTrials.gov